droxidopa has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biaggioni, I; Diedrich, A; McDonell, KE; Muldowney, JAS; Peltier, AC; Preheim, BA; Robertson, D; Shibao, CA | 1 |
| Allen, BB; Avila, EK; Charles, JA; Papadopoulos, E | 1 |
2 other study(ies) available for droxidopa and Critical Illness
| Article | Year |
|---|---|
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.
Topics: Aged; Amyloidosis; Antiparkinson Agents; Autonomic Nervous System Diseases; Cardiovascular Diseases; Comorbidity; Critical Illness; Cross-Sectional Studies; Droxidopa; Female; Hospitalization; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Severity of Illness Index | 2019 |
Neurogenic orthostatic hypotension with critical illness neuropathy treated with droxidopa.
Topics: Adrenergic alpha-Agonists; Aged; Critical Illness; Diabetes Mellitus; Droxidopa; Humans; Hypotension, Orthostatic; Leukemia, Myeloid, Acute; Male | 2016 |